Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares - shares |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|||
| Schedule of anti dilutive common shares [Abstract] | ||||
| Options | 50,000 | |||
| Warrants | 6,064,908 | |||
| Convertible debt | [1] | 932,614 | 682,908 | |
| Total potentially dilutive shares | 7,047,522 | 682,908 | ||
| ||||
| X | ||||||||||
- Definition The number of shares issued in debt conversion converted debt shares in the period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|